Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

One-year postpartum anthropometric outcomes in mothers and children in the LIFE-Moms lifestyle intervention clinical trials.

Phelan S, Clifton RG, Haire-Joshu D, Redman LM, Van Horn L, Evans M, Joshipura K, Couch KA, Arteaga SS, Cahill AG, Drews KL, Franks PW, Gallagher D, Josefson JL, Klein S, Knowler WC, Martin CK, Peaceman AM, Thom EA, Wing RR, Yanovski SZ, Pi-Sunyer X; LIFE-Moms Research Group.

Int J Obes (Lond). 2019 Jul 10. doi: 10.1038/s41366-019-0410-4. [Epub ahead of print]

PMID:
31292531
2.

Impact of Body Weight Dynamics Following Intentional Weight Loss on Fracture Risk: Results from The Action for Health in Diabetes Study.

Beavers KM, Neiberg RH, Johnson KC, Davis CH, Casanova R, Schwartz AV, Crandall CJ, Lewis CE, Pi-Sunyer X, Kritchevsky SB; Look AHEAD Research Group.

JBMR Plus. 2018 Oct 25;3(5):e10086. doi: 10.1002/jbm4.10086. eCollection 2019 May.

3.

Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study.

Apolzan JW, Venditti EM, Edelstein SL, Knowler WC, Dabelea D, Boyko EJ, Pi-Sunyer X, Kalyani RR, Franks PW, Srikanthan P, Gadde KM; Diabetes Prevention Program Research Group.

Ann Intern Med. 2019 May 21;170(10):682-690. doi: 10.7326/M18-1605. Epub 2019 Apr 23.

PMID:
31009939
4.

Ripple Effect of Lifestyle Interventions During Pregnancy on Untreated Partners' Weight.

Hagobian TA, Phelan S, Schaffner A, Brannen A, McHugh A, Ashby-Thompson M, Gorin AA, Pi-Sunyer X, Gallagher D, Wing R.

Obesity (Silver Spring). 2019 May;27(5):733-739. doi: 10.1002/oby.22447. Epub 2019 Apr 8.

PMID:
30957985
5.

Combined effects of cholecystokinin-8 and gastric distension on food intake in humans.

Kissileff HR, Gordon RJ, Thornton JC, Laferrère B, Albu J, Pi-Sunyer X, Geliebter A.

Am J Physiol Regul Integr Comp Physiol. 2019 Jul 1;317(1):R39-R48. doi: 10.1152/ajpregu.00339.2018. Epub 2019 Mar 27.

PMID:
30916576
6.

Erratum. Impact of lifestyle and metformin interventions on the risk of progression to diabetes and regression to normal glucose regulation in overweight or obese people with impaired glucose regulation. Diabetes Care 2017;40:1668-1677.

Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group.

Diabetes Care. 2019 Apr;42(4):701. doi: 10.2337/dc19-er04. No abstract available.

7.

A technology-assisted health coaching intervention vs. enhanced usual care for Primary Care-Based Obesity Treatment: a randomized controlled trial.

Viglione C, Bouwman D, Rahman N, Fang Y, Beasley JM, Sherman S, Pi-Sunyer X, Wylie-Rosett J, Tenner C, Jay M.

BMC Obes. 2019 Feb 4;6:4. doi: 10.1186/s40608-018-0226-0. eCollection 2019.

8.

Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysis.

Pi-Sunyer X, Apovian CM, McElroy SL, Dunayevich E, Acevedo LM, Greenway FL.

Int J Obes (Lond). 2019 Jan 21. doi: 10.1038/s41366-018-0302-z. [Epub ahead of print]

PMID:
30664661
9.

Islet autoantibody positivity in overweight and obese adults with type 2 diabetes.

Pilla SJ, Balasubramanyam A, Knowler WC, Lazo M, Nathan DM, Pi-Sunyer X, Clark JM, Maruthur NM; Look AHEAD Research Group.

Autoimmunity. 2018 Dec;51(8):408-416. doi: 10.1080/08916934.2018.1547711. Epub 2019 Jan 2.

PMID:
30661481
10.

Sex Hormones and Measures of Kidney Function in the Diabetes Prevention Program Outcomes Study.

Kim C, Ricardo AC, Boyko EJ, Christophi CA, Temprosa M, Watson KE, Pi-Sunyer X, Kalyani RR; Diabetes Prevention Program Research Group.

J Clin Endocrinol Metab. 2019 Apr 1;104(4):1171-1180. doi: 10.1210/jc.2018-01495.

PMID:
30398516
11.

Changes in body composition and metabolic disease risk.

Pi-Sunyer X.

Eur J Clin Nutr. 2019 Feb;73(2):231-235. doi: 10.1038/s41430-018-0320-x. Epub 2018 Oct 1. Review.

PMID:
30275524
12.

Lifestyle Interventions Limit Gestational Weight Gain in Women with Overweight or Obesity: LIFE-Moms Prospective Meta-Analysis.

Peaceman AM, Clifton RG, Phelan S, Gallagher D, Evans M, Redman LM, Knowler WC, Joshipura K, Haire-Joshu D, Yanovski SZ, Couch KA, Drews KL, Franks PW, Klein S, Martin CK, Pi-Sunyer X, Thom EA, Van Horn L, Wing RR, Cahill AG; LIFE‐Moms Research Group.

Obesity (Silver Spring). 2018 Sep;26(9):1396-1404. doi: 10.1002/oby.22250. Epub 2018 Sep 6.

13.

Research Priorities for Studies Linking Intake of Low-Calorie Sweeteners and Potentially Related Health Outcomes: Research Methodology and Study Design.

Bright OM, Wang DD, Shams-White M, Bleich SN, Foreyt J, Franz M, Johnson G, Manning BT, Mattes R, Pi-Sunyer X, Schneeman B, Parrott JS, Steffen D, Sylvetsky A, Ziegler P, Chung M.

Curr Dev Nutr. 2017 Jun 8;1(7):e000547. doi: 10.3945/cdn.117.000547. eCollection 2017 Jul.

14.

Erratum. Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation. Diabetes Care 2017;40:1668-1677.

Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group.

Diabetes Care. 2018 Apr;41(4):913. doi: 10.2337/dc18-er04. Epub 2018 Feb 23. No abstract available.

15.

Greater Neonatal Fat-Free Mass and Similar Fat Mass Following a Randomized Trial to Control Excess Gestational Weight Gain.

Gallagher D, Rosenn B, Toro-Ramos T, Paley C, Gidwani S, Horowitz M, Crane J, Lin S, Thornton JC, Pi-Sunyer X.

Obesity (Silver Spring). 2018 Mar;26(3):578-587. doi: 10.1002/oby.22079.

16.

Validation of whole room indirect calorimeters: refinement of current methodologies.

Rising R, Foerster T, Arad AD, Albu J, Pi-Sunyer X.

Physiol Rep. 2017 Nov;5(22). pii: e13521. doi: 10.14814/phy2.13521.

17.

Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m²: A Post-hoc Analysis.

le Roux C, Aroda V, Hemmingsson J, Cancino AP, Christensen R, Pi-Sunyer X.

Obes Facts. 2017;10(6):531-544. doi: 10.1159/000478099. Epub 2017 Nov 17.

18.

Long Term Effect of Intensive Lifestyle Intervention on Cerebral Blood Flow.

Espeland MA, Luchsinger JA, Neiberg RH, Carmichael O, Laurienti PJ, Pi-Sunyer X, Wing RR, Cook D, Horton E, Casanova R, Erickson K, Nick Bryan R; Action for Health in Diabetes Brain Magnetic Resonance Imaging Research Group.

J Am Geriatr Soc. 2018 Jan;66(1):120-126. doi: 10.1111/jgs.15159. Epub 2017 Oct 30.

19.

Physical Function Following a Long-Term Lifestyle Intervention Among Middle Aged and Older Adults With Type 2 Diabetes: The Look AHEAD Study.

Houston DK, Neiberg RH, Miller ME, Hill JO, Jakicic JM, Johnson KC, Gregg EW, Hubbard VS, Pi-Sunyer X, Rejeski WJ, Wing RR, Bantle JP, Beale E, Berkowitz RI, Cassidy-Begay M, Clark JM, Coday M, Delahanty LM, Dutton G, Egan C, Foreyt JP, Greenway FL, Hazuda HP, Hergenroeder A, Horton ES, Jeffery RW, Kahn SE, Kure A, Knowler WC, Lewis CE, Martin CK, Michaels S, Montez MG, Nathan DM, Patricio J, Peters A, Pownall H, Regensteiner J, Steinburg H, Wadden TA, White K, Yanovski SZ, Zhang P, Kritchevsky SB.

J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1552-1559. doi: 10.1093/gerona/glx204.

PMID:
29053861
20.

Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation.

Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group.

Diabetes Care. 2017 Dec;40(12):1668-1677. doi: 10.2337/dc17-1116. Epub 2017 Oct 11. Erratum in: Diabetes Care. 2018 Feb 23;:. Diabetes Care. 2019 Apr;42(4):701.

21.

Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.

Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM; Diabetes Prevention Program Research Group.

Diabetologia. 2017 Sep;60(9):1601-1611. doi: 10.1007/s00125-017-4361-9. Epub 2017 Aug 2. Review.

22.

The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial.

Johnson KC, Bray GA, Cheskin LJ, Clark JM, Egan CM, Foreyt JP, Garcia KR, Glasser S, Greenway FL, Gregg EW, Hazuda HP, Hergenroeder A, Hill JO, Horton ES, Jakicic JM, Jeffery RW, Kahn SE, Knowler WC, Lewis CE, Miller M, Montez MG, Nathan DM, Patricio JL, Peters AL, Pi-Sunyer X, Pownall HJ, Reboussin D, Redmon JB, Steinberg H, Wadden TA, Wagenknecht LE, Wing RR, Womack CR, Yanovski SZ, Zhang P, Schwartz AV; Look AHEAD Study Group.

J Bone Miner Res. 2017 Nov;32(11):2278-2287. doi: 10.1002/jbmr.3214. Epub 2017 Jul 28.

23.

Changes in Visceral Adiposity, Subcutaneous Adiposity, and Sex Hormones in the Diabetes Prevention Program.

Kim C, Dabelea D, Kalyani RR, Christophi CA, Bray GA, Pi-Sunyer X, Darwin CH, Yalamanchi S, Barrett-Connor E, Golden SH, Boyko EJ.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3381-3389. doi: 10.1210/jc.2017-00967.

24.

A 12-week randomized clinical trial investigating the potential for sucralose to affect glucose homeostasis.

Grotz VL, Pi-Sunyer X, Porte D Jr, Roberts A, Richard Trout J.

Regul Toxicol Pharmacol. 2017 Aug;88:22-33. doi: 10.1016/j.yrtph.2017.05.011. Epub 2017 May 11.

25.

Polyphenol Levels Are Inversely Correlated with Body Weight and Obesity in an Elderly Population after 5 Years of Follow Up (The Randomised PREDIMED Study).

Guo X, Tresserra-Rimbau A, Estruch R, Martínez-González MA, Medina-Remón A, Fitó M, Corella D, Salas-Salvadó J, Portillo MP, Moreno JJ, Pi-Sunyer X, Lamuela-Raventós RM.

Nutrients. 2017 May 3;9(5). pii: E452. doi: 10.3390/nu9050452.

26.

Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment.

Espeland MA, Luchsinger JA, Baker LD, Neiberg R, Kahn SE, Arnold SE, Wing RR, Blackburn GL, Bray G, Evans M, Hazuda HP, Jeffery RW, Wilson VM, Clark JM, Coday M, Demos-McDermott K, Foreyt JP, Greenway F, Hill JO, Horton ES, Jakicic JM, Johnson KC, Knowler WC, Lewis CE, Nathan DM, Peters A, Pi-Sunyer X, Pownall H, Wadden TA, Rapp SR; Look AHEAD Study Group.

Neurology. 2017 May 23;88(21):2026-2035. doi: 10.1212/WNL.0000000000003955. Epub 2017 Apr 26.

27.

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.

le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group.

Lancet. 2017 Apr 8;389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7. Epub 2017 Feb 23. Erratum in: Lancet. 2017 Apr 8;389(10077):1398.

PMID:
28237263
28.

A New Whole Room Indirect Calorimeter for Measurement of the Energetics of Exercise.

Rising R, Whyte K, Albu J, Pi-Sunyer X.

J Exerc Physiol Online. 2016 Dec;19(6):156-169.

30.

Changes in skeletal muscle and organ size after a weight-loss intervention in overweight and obese type 2 diabetic patients.

Gallagher D, Kelley DE, Thornton J, Boxt L, Pi-Sunyer X, Lipkin E, Nyenwe E, Janumala I, Heshka S; MRI Ancillary Study Group of the Look AHEAD Research Group.

Am J Clin Nutr. 2017 Jan;105(1):78-84. doi: 10.3945/ajcn.116.139188. Epub 2016 Nov 23.

31.

Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects.

Bays H, Pi-Sunyer X, Hemmingsson JU, Claudius B, Jensen CB, Van Gaal L.

Curr Med Res Opin. 2017 Feb;33(2):225-229. doi: 10.1080/03007995.2016.1251892. Epub 2016 Nov 6.

PMID:
27817208
32.

Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.

Look AHEAD Research Group, Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Clark JM, Coday M, Curtis JM, Egan C, Evans M, Foreyt J, Foster G, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jeffery RW, Johnson KC, Kitabchi AE, Knowler WC, Kriska A, Lang W, Lewis CE, Montez MG, Nathan DM, Neiberg RH, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Redmon B, Regensteiner J, Rejeski J, Ribisl PM, Safford M, Stewart K, Trence D, Wadden TA, Wing RR, Yanovski SZ.

Lancet Diabetes Endocrinol. 2016 Nov;4(11):913-921. doi: 10.1016/S2213-8587(16)30162-0. Epub 2016 Aug 30.

33.

EFFECTS OF LIRAGLUTIDE 3.0 MG ON WEIGHT AND RISK FACTORS IN HISPANIC VERSUS NON-HIPANIC POPULATIONS: SUBGROUP ANALYSIS FROM SCALE RANDOMIZED TRIALS.

O'Neil PM, Garvey WT, Gonzalez-Campoy JM, Mora P, Ortiz RV, Guerrero G, Claudius B, Pi-Sunyer X; Satiety and Clinical Adiposity – Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups.

Endocr Pract. 2016 Nov;22(11):1277-1287. Epub 2016 Aug 2.

PMID:
27482610
34.

Impact of lorcaserin on glycemic control in overweight and obese patients with type 2 diabetes: analysis of week 52 responders and nonresponders.

Pi-Sunyer X, Shanahan W, Fain R, Ma T, Garvey WT.

Postgrad Med. 2016 Aug;128(6):591-7. doi: 10.1080/00325481.2016.1208618. Epub 2016 Jul 18.

PMID:
27389084
35.

Testosterone and depressive symptoms among men in the Diabetes Prevention Program.

Kim C, Barrett-Connor E, Aroda VR, Mather KJ, Christophi CA, Horton ES, Pi-Sunyer X, Bray GA, Labrie F, Golden SH; Diabetes Prevention Program Research Group.

Psychoneuroendocrinology. 2016 Oct;72:63-71. doi: 10.1016/j.psyneuen.2016.06.009. Epub 2016 Jun 15.

36.

Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials.

Ard J, Cannon A, Lewis CE, Lofton H, Vang Skjøth T, Stevenin B, Pi-Sunyer X.

Diabetes Obes Metab. 2016 Apr;18(4):430-5. doi: 10.1111/dom.12632. Epub 2016 Feb 11.

37.

Evaluation of a new whole room indirect calorimeter specific for measurement of resting metabolic rate.

Rising R, Whyte K, Albu J, Pi-Sunyer X.

Nutr Metab (Lond). 2015 Nov 19;12:46. doi: 10.1186/s12986-015-0043-0. eCollection 2015.

38.

Liraglutide in Weight Management.

Pi-Sunyer X; SCALE Obesity and Prediabetes Investigators.

N Engl J Med. 2015 Oct 29;373(18):1781-2. doi: 10.1056/NEJMc1509759. No abstract available.

PMID:
26510028
39.

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.

Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group.

N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892.

40.

Weight change in the first 2 months of a lifestyle intervention predicts weight changes 8 years later.

Unick JL, Neiberg RH, Hogan PE, Cheskin LJ, Dutton GR, Jeffery R, Nelson JA, Pi-Sunyer X, West DS, Wing RR; Look AHEAD Research Group.

Obesity (Silver Spring). 2015 Jul;23(7):1353-6. doi: 10.1002/oby.21112.

41.

Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.

Kim C, Christophi CA, Goldberg RB, Perreault L, Dabelea D, Marcovina SM, Pi-Sunyer X, Barrett-Connor E.

Diabet Med. 2016 Jan;33(1):32-8. doi: 10.1111/dme.12799. Epub 2015 May 29.

42.

The Look AHEAD Trial: A Review and Discussion Of Its Outcomes.

Pi-Sunyer X.

Curr Nutr Rep. 2014 Dec;3(4):387-391.

43.

Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.

Espeland MA, Glick HA, Bertoni A, Brancati FL, Bray GA, Clark JM, Curtis JM, Egan C, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Hazuda HP, Hill JO, Hire D, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Killean T, Kitabchi AE, Knowler WC, Kriska A, Lewis CE, Miller M, Montez MG, Murillo A, Nathan DM, Nyenwe E, Patricio J, Peters AL, Pi-Sunyer X, Pownall H, Redmon JB, Rushing J, Ryan DH, Safford M, Tsai AG, Wadden TA, Wing RR, Yanovski SZ, Zhang P; Look AHEAD Research Group.

Diabetes Care. 2014 Sep;37(9):2548-56. doi: 10.2337/dc14-0093.

44.

Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial.

Rubin RR, Wadden TA, Bahnson JL, Blackburn GL, Brancati FL, Bray GA, Coday M, Crow SJ, Curtis JM, Dutton G, Egan C, Evans M, Ewing L, Faulconbridge L, Foreyt J, Gaussoin SA, Gregg EW, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Knowler WC, Lang W, Lewis CE, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Rejeski WJ, Rosenthal RH, Ruelas V, Toledo K, Van Dorsten B, Vitolins M, Williamson D, Wing RR, Yanovski SZ, Zhang P; Look AHEAD Research Group.

Diabetes Care. 2014 Jun;37(6):1544-53. doi: 10.2337/dc13-1928.

45.

Bariatric surgery for the treatment of Type 2 diabetes: a step closer?

Chantziara K, Laferrère B, Pi-Sunyer X.

Expert Rev Endocrinol Metab. 2014 May;9(3):231-237. doi: 10.1586/17446651.2014.894876. Epub 2014 Mar 25.

PMID:
30736162
46.

We stand by our guidelines.

Pi-Sunyer X, Jensen M, Ryan D, Apovian C, Millen B, Nonas C.

Nat Rev Endocrinol. 2014 May;10(5):310. doi: 10.1038/nrendo.2013.271-c1. Epub 2014 Mar 11. No abstract available.

PMID:
24614261
47.

Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.

Florez H, Temprosa MG, Orchard TJ, Mather KJ, Marcovina SM, Barrett-Connor E, Horton E, Saudek C, Pi-Sunyer XF, Ratner RE, Goldberg RB; Diabetes Prevention Program Research Group.

Diabetes Obes Metab. 2014 Apr;16(4):326-33. doi: 10.1111/dom.12220. Epub 2013 Oct 29.

48.

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.

Look AHEAD Research Group, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZ.

N Engl J Med. 2013 Jul 11;369(2):145-54. doi: 10.1056/NEJMoa1212914. Epub 2013 Jun 24. Erratum in: N Engl J Med. 2014 May 8;370(19):1866.

49.

Sex hormone binding globulin and sex steroids among premenopausal women in the diabetes prevention program.

Kim C, Pi-Sunyer X, Barrett-Connor E, Stentz FB, Murphy MB, Kong S, Nan B, Kitabchi AE; Diabetes Prevention Program Research Group.

J Clin Endocrinol Metab. 2013 Jul;98(7):3049-57. doi: 10.1210/jc.2013-1341. Epub 2013 May 24.

50.

The relationship between obstructive sleep apnea and self-reported stroke or coronary heart disease in overweight and obese adults with type 2 diabetes mellitus.

Rice TB, Foster GD, Sanders MH, Unruh M, Reboussin D, Kuna ST, Millman R, Zammit G, Wing RR, Wadden TA, Kelley D, Pi-Sunyer X, Newman AB; Sleep AHEAD Research Group.

Sleep. 2012 Sep 1;35(9):1293-8.

Supplemental Content

Loading ...
Support Center